Close Menu

DNAnexus

DNANexus said this week that it has signed an agreement with Geisinger Health System that should yield clinically relevant workflows for the use of genome sequence data in medicine.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – DNAnexus today announced deals with the Geisinger Health System and the University of California, San Francisco to develop clinically relevant workflows.

By Uduak Grace Thomas
Over the last year, sequencing vendors have paid more than a passing interest to the genomic data analysis market and are taking tentative steps to etch a place for themselves in the space.

This story was originally published Oct. 17.

Paired Ends: Oct 18, 2011

Premium

DNAnexus has added two new board members: Krishna Yeshwant and Geoff Duyk.

By Uduak Grace Thomas
This story has been updated from a version posted Oct. 12 to include additional comments.

This article has been updated to correct the sixth paragraph, which had incorrectly stated that Google Cloud Storage will take over hosting of the SRA from the National Center for Biotechnology Information.

Complete Genomics customers will have access to DNAnexus’ suite of informatics tools, via Amazon web services, that will, among other features, enable them to query multiple human genomes and visualize structural and copy-number variations, and small variants.

DNAnexus will also host human genome datasets that Complete Genomics previously released publicly and will make them available as reference data to its customers.

Pages

A federal judge has ruled that drug companies, device manufacturers, and universities need to provide missing clinical data from hundreds of trials to a federal website, ScienceInsider reports.

A genetic analysis suggests red pandas might actually belong to two different species, New Scientist reports.

NPR reports that the US Centers for Disease Control and Prevention has fixed the problem with some of its SARS-CoV-2 testing kits.

In Nature this week: epigenetic factors that prevent healthy aging and more.